Manta Pharma LLC
Manta Pharma develops an active implantable medical device that combines a drug formulation, micro-pump, and biosensor coordinated by an AI engine to deliver medications subcutaneously with real-time adjustment based on patient needs. The company targets chronic disease treatment including autoimmune diseases, diabetes, substance use disorders, HIV/AIDS, cardiovascular disease, COPD, asthma, chronic kidney and liver diseases, CNS disorders, chronic pain, cancer, and neurodegenerative conditions. The system integrates a temperature-stable drug formulation, intelligent micro-pump, and biosensor components.
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Manta Pharma LLC | Gaithersburg | MD | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.